Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
R Chowdhury, H Khan, E Heydon… - European heart …, 2013 - academic.oup.com
Aims The aim of this study was to determine the extent to which adherence to individual
vascular medications, assessed by different methods, influences the absolute and relative …
vascular medications, assessed by different methods, influences the absolute and relative …
Cardiac rehabilitation delivery model for low-resource settings
SL Grace, KI Turk-Adawi, A Contractor, A Atrey… - Heart, 2016 - heart.bmj.com
Objective Cardiovascular disease is a global epidemic, which is largely preventable.
Cardiac rehabilitation (CR) is demonstrated to be cost-effective and efficacious in high …
Cardiac rehabilitation (CR) is demonstrated to be cost-effective and efficacious in high …
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Background Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events
after percutaneous coronary intervention (PCI). Whether risk changes over time, depends on …
after percutaneous coronary intervention (PCI). Whether risk changes over time, depends on …
Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery
D Capodanno, DJ Angiolillo - Circulation, 2013 - Am Heart Assoc
2786 Circulation December 24/31, 2013 platelet adhesiveness, persistently high platelet
counts, and decreased or impaired fibrinolysis. 20–22 Adding to the withdrawal of protection …
counts, and decreased or impaired fibrinolysis. 20–22 Adding to the withdrawal of protection …
New horizons in subdural haematoma
F Rickard, J Gale, A Williams, D Shipway - Age and Ageing, 2023 - academic.oup.com
Subdural haematoma (SDH) is a common injury sustained by older people living with frailty
and multimorbidity, and typically following falls from a standing height. Anticoagulant and …
and multimorbidity, and typically following falls from a standing height. Anticoagulant and …
Adherence to dual antiplatelet therapy after coronary stenting: a systematic review
MJ Czarny, AS Nathan, RW Yeh, L Mauri - Clinical cardiology, 2014 - Wiley Online Library
Background Adherence to dual antiplatelet therapy (DAPT) is critical after coronary stenting.
Although adherence rates are frequently assessed in clinical trials, adherence rates in the …
Although adherence rates are frequently assessed in clinical trials, adherence rates in the …
Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials
A Kubica, K Obońska, T Fabiszak… - Current medical research …, 2016 - Taylor & Francis
Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary
syndromes (ACS) and/or undergoing percutaneous coronary interventions. Non-adherence …
syndromes (ACS) and/or undergoing percutaneous coronary interventions. Non-adherence …
Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy
DE Cutlip, DJ Kereiakes, L Mauri, R Stoler… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: This study sought to assess the frequency and clinical impact of dual antiplatelet
therapy (DAPT) nonadherence. Background: There are limited data on the impact of DAPT …
therapy (DAPT) nonadherence. Background: There are limited data on the impact of DAPT …
Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent …
F Saia, LMB Belotti, P Guastaroba… - … Quality and Outcomes, 2016 - Am Heart Assoc
Background—Epidemiology and consequences of surgery in patients with coronary stents
are not clearly defined, as well as the impact of different stent types in relationship with …
are not clearly defined, as well as the impact of different stent types in relationship with …
Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported …
A Kubica, A Kosobucka, T Fabiszak… - Current Medical …, 2019 - Taylor & Francis
Introduction: Non-adherence to medication regimen after myocardial infarction (MI) leads to
increased morbidity and mortality and generates additional cost to the healthcare system …
increased morbidity and mortality and generates additional cost to the healthcare system …